You are currently viewing a new version of our website. To view the old version click .

Current Oncology, Volume 32, Issue 6

June 2025 - 77 articles

Cover Story: Myelofibrosis is a progressive myeloproliferative neoplasm characterized by splenomegaly, cytopenias, and debilitating symptoms. While ruxolitinib remains a first-line treatment, many patients discontinue due to intolerance or resistance. This review outlines current and emerging therapeutic options following ruxolitinib failure, including fedratinib, momelotinib, pacritinib, and novel agents in clinical trials. A personalized, risk-adapted approach is essential for optimizing outcomes in this complex disease. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (77)

  • Case Report
  • Open Access
1,481 Views
8 Pages

A Neuropsychiatric Prelude to Unveiling Small Cell Lung Cancer with Suspected Paraneoplastic Limbic Encephalitis: A Case Report

  • Jessa Letargo,
  • X. Melody Qu,
  • Timothy K. Nguyen,
  • Alexander V. Louie,
  • Sara Kuruvilla and
  • Enxhi Kotrri

Small cell lung cancer (SCLC) is an aggressive form of lung cancer characterized by rapid growth and early metastases. As a neuroendocrine tumour, SCLC is especially notorious for various paraneoplastic syndromes, one of which is a rare neurological...

  • Systematic Review
  • Open Access
1 Citations
1,794 Views
12 Pages

KRAS Mutations as Predictive Biomarkers for First-Line Immune Checkpoint Inhibitor Monotherapy in Advanced NSCLC: A Systematic Review and Meta-Analysis

  • Filip Marković,
  • Jelena Milin-Lazović,
  • Nikola Nikolić,
  • Aleksa Golubović,
  • Mihailo Stjepanović and
  • Milica Kontić

Recent research suggests a link between KRAS mutations and the effectiveness of ICIs, as KRAS-driven tumors may possess unique immunogenic features that influence the tumor microenvironment. These mutations can increase tumor mutation burden (TMB) an...

  • Article
  • Open Access
2 Citations
743 Views
17 Pages

Textbook Outcomes for Retroperitoneal Sarcoma Resection: A Multi-Centre Review

  • Skyle Murphy,
  • Christopher Allan,
  • Andrew Barbour,
  • Victoria Donoghue and
  • B. Mark Smithers

For patients with retroperitoneal sarcomas (RPSs), en-bloc resection with macroscopically negative margins remains the only potentially curative treatment. Textbook outcomes (TOs) are composite measures developed to compare ideal surgical outcomes fo...

  • Article
  • Open Access
764 Views
16 Pages

Background: The Global Leadership Initiative on Malnutrition (GLIM) criteria provide a standardized approach for assessing the nutritional status of patients and demonstrate strong predictive value for the prognosis of patients with gastric cancer. H...

  • Review
  • Open Access
1 Citations
3,637 Views
18 Pages

The Relationship Between Obesity and Cancer: Epidemiology, Pathophysiology, and the Effect of Obesity Treatment on Cancer

  • Yasmin Ingram,
  • Oluwasegun Olujide,
  • Nabiha Sheikh,
  • Alice Robinson,
  • Jan Hoong Ho,
  • Akheel A. Syed and
  • Safwaan Adam

There is growing evidence relating to the risk of cancer in people with obesity. Obesity is already established as one of the strongest predisposing factors to cancer, and ‘obesity-related’ cancers have been defined in previous studies. I...

  • Article
  • Open Access
855 Views
18 Pages

SUPPORT MY WAY: Supporting Young People After Treatment for Cancer: What Is Needed, When This Is Needed and How This Can Be Best Delivered

  • Nicole Collaço,
  • Charlotte Ralph,
  • Peter Dawes,
  • Anne-Sophie Darlington,
  • Andrew Davies,
  • Ramya Ramanujachar,
  • Louise Hooker and
  • Samantha Sodergren

As survival rates for teenagers and young adults (TYAs) with cancer exceed 80%, they are living longer post treatment, yet often experience prolonged health and quality of life concerns. Many TYAs also experience unmet support needs. This study aimed...

  • Article
  • Open Access
1,139 Views
18 Pages

Dosimetric Comparison of VMAT Alone and VMAT with HDR Brachytherapy Boost Using Clinical and Biological Dose Models in Localized Prostate Cancer

  • Manuel Guhlich,
  • Olga Knaus,
  • Arne Strauss,
  • Laura Anna Fischer,
  • Jann Fischer,
  • Stephanie Bendrich,
  • Sandra Donath,
  • Leif Hendrik Dröge,
  • Martin Leu and
  • Stefan Rieken
  • + 3 authors

Background: Combining external beam radiotherapy (EBRT) with high-dose-rate (HDR) brachytherapy (BT) enables biologically effective dose escalation in prostate cancer. However, comparative evaluation of such regimens using radiobiological modeling re...

  • Review
  • Open Access
2 Citations
3,993 Views
17 Pages

Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance

  • Braden Millan,
  • Lauren Loebach,
  • Ruben Blachman-Braun,
  • Milan H. Patel,
  • Jaskirat Saini,
  • W. Marston Linehan and
  • Mark W. Ball

Molecular testing in renal cell carcinoma (RCC) has allowed for a better understanding of the biology of both sporadic and hereditary diseases, where genetic testing is currently recommended in the guidelines for a select population with risk factors...

  • Article
  • Open Access
1,455 Views
11 Pages

Comparison of Mortality and Morbidity of Robotic Versus Laparoscopic Radical Nephrectomy for the Treatment of Renal Cell Carcinoma—An Analysis of the National Surgery Quality Improvement Program (NSQIP) Targeted Nephrectomy Database

  • Vatsala Mundra,
  • Siqi Hu,
  • Renil Sinu Titus,
  • Eusebio Luna-Velazquez,
  • Zachary Melchiode,
  • Jiaqiong Xu,
  • Carlos Riveros,
  • Sanjana Ranganathan,
  • Emily Huang and
  • Brian J. Miles
  • + 3 authors

Objectives: To compare the perioperative complications between robot-assisted (RARN) and laparoscopic (LRN) radical nephrectomy for the treatment of renal cell carcinoma (RCC). Methods: We conducted a retrospective study using the National Surgical Q...

  • Guidelines
  • Open Access
1,535 Views
35 Pages

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

  • Toni Zhong,
  • Glenn G. Fletcher,
  • Muriel Brackstone,
  • Simon G. Frank,
  • Renee Hanrahan,
  • Vivian Miragias,
  • Christiaan Stevens,
  • Danny Vesprini,
  • Alyssa Vito and
  • Frances C. Wright

Several postmastectomy breast reconstruction techniques and procedures have been implemented, although with limited evaluation of benefits and adverse effects. We conducted a systematic review on the plane and timing of reconstruction, and on the use...

of 8

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729